
Self tests from the drugstore or pharmacy and blood tests from an accredited lab differ clearly in method and reliability. Knowing both options makes it easier to judge when which test makes sense.
A self test is usually a point of care rapid test that delivers a result on the spot, often qualitatively or semi-quantitatively. A lab test analyses the sample in an accredited lab with standardised, validated procedures and delivers quantitative values with documented precision.
Point of care tests are designed for speed and easy handling, for example as a test strip or cassette test. Lab methods such as immunoassays or chromatography are more elaborate but as a rule more precise and better reproducible. For many questions a rapid test is enough for a first orientation, while a reliable answer often needs the lab analysis. What matters is judging the claim of each test realistically: a rapid test usually answers a single, narrowly framed question, while a lab analysis often delivers several parameters at once and at higher resolution.
Accredited lab tests go through stricter quality controls and both internal and external ring trials, which raises accuracy and comparability across different labs. Rapid tests can show larger swings in sensitivity and specificity depending on the manufacturer and the test principle, especially at low concentrations or at thresholds close to the reference range.
The overview below sets the two side by side on place of testing, kind of result, quality assurance and typical use.
| Criterion | Self test | Lab test |
|---|---|---|
| Place of testing | At home or in the pharmacy, immediately | Lab, usually after the sample is sent in |
| Kind of result | Often qualitative (positive or negative) | Usually quantitative with a measured value |
| Quality assurance | Depends on the manufacturer | Accreditation, ring trials |
| Typical use | First orientation, monitoring over time | Diagnostic clarification |
The important measures are sensitivity (how many genuinely positive cases are detected) and specificity (how many genuinely negative cases are correctly ruled out). Both values depend on the individual test kit and can be found in the package insert or in the manufacturer's information. A blanket statement like "self tests are inaccurate" falls short, because the range is wide and depends on the product.
A self test suits a first assessment or close monitoring over time, for example with values that are already known and a stable clinical picture. For a medical diagnosis, unclear symptoms or thresholds close to the reference range, an accredited lab analysis is the more reliable basis.
Take blood sugar as an example: a self-measuring device is practical in everyday life for monitoring over time, while the diagnosis of diabetes rests on standardised lab values. It works similarly for many biomarkers, where an unusual signal from a self test should be confirmed by a lab analysis before conclusions are reached.
The way the sample is collected affects the result considerably, and capillary blood from the fingertip can differ slightly in composition from venous blood. Errors in collection, storage or transport can reduce accuracy regardless of the test procedure.
Capillary measurements, for example with systems like Tasso+, are already possible today within established offerings and suitable for many parameters. For certain questions, however, a venous blood draw is intended. Since the ApoVWG came into force on 2 July 2026, licensed pharmacists may also draw venous blood after doctor-led training, once the joint model curriculum of the Federal Chamber of Pharmacists and the German Medical Association is available. For pharmacy technicians (PTA) this is not provided for as things stand.
Sensitivity states how reliably a test detects an abnormality that is actually present, and specificity how reliably it classifies unremarkable cases correctly as such. No test reaches 100 percent on both values, so a residual risk of false positive or false negative results always remains.
These measures are normally in the instructions for use or in the CE marking of the product. Anyone who cannot find or interpret them should get advice at the pharmacy or from their treating doctor. A single unusual value, whether from a self test or from the lab, is never a diagnosis, it is a reason for further medical clarification. Context counts too: pre-test probability, symptoms and history influence how a result is to be assessed, which is why the same number can be interpreted differently for two people.
Pharmacies can explain what a self test is suitable for, where a lab analysis makes more sense, and support capillary measurements within established offerings. The interpretation of results stays informational, while the medical diagnosis belongs in medical hands.
With the ApoVWG, in force since 2 July 2026, the possibilities in the pharmacy widen in prospect as well: once the model curriculum for the venous blood draw is available, trained pharmacists can draw venous blood in addition to the capillary measurement. That does not change the fact that advice on the accuracy of self tests and lab tests remains information and replaces no diagnosis.
Diagnostic self tests sold in the EU need a CE mark under the regulation on in vitro diagnostics. That means basic requirements for safety and performance, but it does not replace the quality control of an accredited lab.
As a rule not completely. Self tests are well suited to orientation or to monitoring over time, while for a diagnostic answer or in the presence of symptoms an accredited lab analysis with medical interpretation is the more reliable basis.
Differences can arise from the test principle, the kind of sample (capillary versus venous), the timing of the measurement or the pre-analytics. Small handling errors also have a stronger effect with a self test than in standardised lab processes.
A point of care test is carried out directly on site, for example in the pharmacy or at home, without sending it to an external lab. It delivers a result quickly but is often simpler in method than a lab analysis.
Pharmacy teams can explain how a test works, what the result means and whether further medical clarification makes sense. Making a medical diagnosis remains the task of the doctor's practice.
Aniva provides the complete blood diagnostics infrastructure for the local pharmacy, including the lab, the result, the app report and the logistics. Learn more at Aniva for pharmacies and on the page for Tasso+ capillary blood.
As of 4 August 2026. Aniva Health editorial team, no warranty. A single blood value is not a diagnosis and does not replace a visit to your doctor.